HEADER VIRAL PROTEIN/IMMUNE SYSTEM 11-SEP-21 7S5P TITLE CRYSTAL STRUCTURE OF SARS-COV-2 B.1.351 VARIANT RECEPTOR BINDING TITLE 2 DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY CS23 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SPIKE PROTEIN S1; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: CS23 HEAVY CHAIN; COMPND 7 CHAIN: H; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: CS23 LIGHT CHAIN; COMPND 11 CHAIN: L; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 3 2; SOURCE 4 ORGANISM_COMMON: 2019-NCOV, SARS-COV-2; SOURCE 5 ORGANISM_TAXID: 2697049; SOURCE 6 GENE: S, 2; SOURCE 7 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 8 EXPRESSION_SYSTEM_COMMON: CABBAGE LOOPER; SOURCE 9 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 EXPRESSION_SYSTEM: MUS MUSCULUS; SOURCE 15 EXPRESSION_SYSTEM_COMMON: HOUSE MOUSE; SOURCE 16 EXPRESSION_SYSTEM_TAXID: 10090; SOURCE 17 MOL_ID: 3; SOURCE 18 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 19 ORGANISM_COMMON: HUMAN; SOURCE 20 ORGANISM_TAXID: 9606; SOURCE 21 EXPRESSION_SYSTEM: MUS MUSCULUS; SOURCE 22 EXPRESSION_SYSTEM_COMMON: HOUSE MOUSE; SOURCE 23 EXPRESSION_SYSTEM_TAXID: 10090 KEYWDS SARS-COV-2, CORONAVIRUS, ANTIBODY, FAB, VOC, BETA, B.1.351, SPIKE, KEYWDS 2 RBD, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.YUAN,I.A.WILSON REVDAT 2 18-OCT-23 7S5P 1 REMARK REVDAT 1 09-MAR-22 7S5P 0 JRNL AUTH S.M.REINCKE,M.YUAN,H.C.KORNAU,V.M.CORMAN,S.VAN HOOF, JRNL AUTH 2 E.SANCHEZ-SENDIN,M.RAMBERGER,W.YU,Y.HUA,H.TIEN,M.L.SCHMIDT, JRNL AUTH 3 T.SCHWARZ,L.M.JEWOROWSKI,S.E.BRANDL,H.F.RASMUSSEN, JRNL AUTH 4 M.A.HOMEYER,L.STOFFLER,M.BARNER,D.KUNKEL,S.HUO,J.HORLER, JRNL AUTH 5 N.VON WARDENBURG,I.KROIDL,T.M.ESER,A.WIESER,C.GELDMACHER, JRNL AUTH 6 M.HOELSCHER,H.GANZER,G.WEISS,D.SCHMITZ,C.DROSTEN,H.PRUSS, JRNL AUTH 7 I.A.WILSON,J.KREYE JRNL TITL SARS-COV-2 BETA VARIANT INFECTION ELICITS POTENT JRNL TITL 2 LINEAGE-SPECIFIC AND CROSS-REACTIVE ANTIBODIES. JRNL REF SCIENCE V. 375 782 2022 JRNL REFN ESSN 1095-9203 JRNL PMID 35076281 JRNL DOI 10.1126/SCIENCE.ABM5835 REMARK 2 REMARK 2 RESOLUTION. 2.86 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.2_4158 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.86 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.21 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 28467 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.211 REMARK 3 R VALUE (WORKING SET) : 0.208 REMARK 3 FREE R VALUE : 0.247 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.030 REMARK 3 FREE R VALUE TEST SET COUNT : 2000 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 49.2100 - 6.8900 1.00 2054 155 0.2234 0.2267 REMARK 3 2 6.8900 - 5.4700 1.00 1945 147 0.2007 0.2492 REMARK 3 3 5.4700 - 4.7800 1.00 1921 145 0.1677 0.2125 REMARK 3 4 4.7800 - 4.3400 1.00 1895 143 0.1524 0.1865 REMARK 3 5 4.3400 - 4.0300 1.00 1886 143 0.1664 0.1987 REMARK 3 6 4.0300 - 3.7900 1.00 1902 144 0.1839 0.2513 REMARK 3 7 3.7900 - 3.6000 1.00 1859 140 0.2095 0.2226 REMARK 3 8 3.6000 - 3.4500 1.00 1877 142 0.2146 0.2746 REMARK 3 9 3.4500 - 3.3100 1.00 1869 141 0.2318 0.2528 REMARK 3 10 3.3100 - 3.2000 1.00 1864 141 0.2453 0.3045 REMARK 3 11 3.2000 - 3.1000 1.00 1857 140 0.2492 0.3145 REMARK 3 12 3.1000 - 3.0100 1.00 1860 141 0.2699 0.3348 REMARK 3 13 3.0100 - 2.9300 1.00 1845 140 0.2965 0.3285 REMARK 3 14 2.9300 - 2.8600 0.99 1833 138 0.3306 0.3851 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.370 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.150 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 48.78 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 52.67 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7S5P COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-SEP-21. REMARK 100 THE DEPOSITION ID IS D_1000259654. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-MAY-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 9.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97741 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28522 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.860 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 24.50 REMARK 200 R MERGE (I) : 0.25600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 2.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.86 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.91 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.5 REMARK 200 DATA REDUNDANCY IN SHELL : 14.80 REMARK 200 R MERGE FOR SHELL (I) : 1.34600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 6XC2 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 70.27 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.14 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.6 M AMMONIUM SULFATE AND 0.1 M REMARK 280 BICINE PH 9.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 55.99700 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 72.94900 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 72.94900 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 27.99850 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 72.94900 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 72.94900 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 83.99550 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 72.94900 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 72.94900 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 27.99850 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 72.94900 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 72.94900 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 83.99550 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 55.99700 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8150 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 27380 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -162.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, H, L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ARG A 319 REMARK 465 VAL A 320 REMARK 465 GLN A 321 REMARK 465 PRO A 322 REMARK 465 THR A 323 REMARK 465 GLU A 324 REMARK 465 SER A 325 REMARK 465 ILE A 326 REMARK 465 VAL A 327 REMARK 465 ARG A 328 REMARK 465 PHE A 329 REMARK 465 PRO A 330 REMARK 465 ASN A 331 REMARK 465 ILE A 332 REMARK 465 THR A 333 REMARK 465 LYS A 528 REMARK 465 LYS A 529 REMARK 465 SER A 530 REMARK 465 THR A 531 REMARK 465 ASN A 532 REMARK 465 LEU A 533 REMARK 465 VAL A 534 REMARK 465 LYS A 535 REMARK 465 ASN A 536 REMARK 465 LYS A 537 REMARK 465 CYS A 538 REMARK 465 VAL A 539 REMARK 465 ASN A 540 REMARK 465 PHE A 541 REMARK 465 SER A 542 REMARK 465 GLY A 543 REMARK 465 HIS A 544 REMARK 465 HIS A 545 REMARK 465 HIS A 546 REMARK 465 HIS A 547 REMARK 465 HIS A 548 REMARK 465 HIS A 549 REMARK 465 SER H 128 REMARK 465 LYS H 129 REMARK 465 SER H 130 REMARK 465 THR H 131 REMARK 465 SER H 132 REMARK 465 GLY H 133 REMARK 465 GLY H 134 REMARK 465 SER H 215 REMARK 465 CYS H 216 REMARK 465 GLU L 210 REMARK 465 CYS L 211 REMARK 465 SER L 212 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 VAL H 184 CG1 CG2 REMARK 470 SER H 187 OG REMARK 470 SER H 188 OG REMARK 470 LEU H 189 CG CD1 CD2 REMARK 470 THR H 191 OG1 CG2 REMARK 470 GLN H 192 CG CD OE1 NE2 REMARK 470 THR H 193 OG1 CG2 REMARK 470 GLU H 212 CG CD OE1 OE2 REMARK 470 LYS H 214 CG CD CE NZ REMARK 470 GLN L 126 CG CD OE1 NE2 REMARK 470 SER L 190 OG REMARK 470 THR L 209 OG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O GLU L 183 OG SER L 187 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 422 -52.73 -120.95 REMARK 500 ASN A 487 14.90 59.42 REMARK 500 TYR H 100 -9.09 72.42 REMARK 500 ASP L 51 -19.22 71.62 REMARK 500 GLN L 108 144.60 -171.48 REMARK 500 ASP L 151 -95.07 57.63 REMARK 500 REMARK 500 REMARK: NULL DBREF 7S5P A 319 541 UNP P0DTC2 SPIKE_SARS2 319 541 DBREF 7S5P H 1 216 PDB 7S5P 7S5P 1 216 DBREF 7S5P L 2 212 PDB 7S5P 7S5P 2 212 SEQADV 7S5P ASN A 417 UNP P0DTC2 LYS 417 VARIANT SEQADV 7S5P LYS A 484 UNP P0DTC2 GLU 484 VARIANT SEQADV 7S5P TYR A 501 UNP P0DTC2 ASN 501 VARIANT SEQADV 7S5P SER A 542 UNP P0DTC2 EXPRESSION TAG SEQADV 7S5P GLY A 543 UNP P0DTC2 EXPRESSION TAG SEQADV 7S5P HIS A 544 UNP P0DTC2 EXPRESSION TAG SEQADV 7S5P HIS A 545 UNP P0DTC2 EXPRESSION TAG SEQADV 7S5P HIS A 546 UNP P0DTC2 EXPRESSION TAG SEQADV 7S5P HIS A 547 UNP P0DTC2 EXPRESSION TAG SEQADV 7S5P HIS A 548 UNP P0DTC2 EXPRESSION TAG SEQADV 7S5P HIS A 549 UNP P0DTC2 EXPRESSION TAG SEQRES 1 A 231 ARG VAL GLN PRO THR GLU SER ILE VAL ARG PHE PRO ASN SEQRES 2 A 231 ILE THR ASN LEU CYS PRO PHE GLY GLU VAL PHE ASN ALA SEQRES 3 A 231 THR ARG PHE ALA SER VAL TYR ALA TRP ASN ARG LYS ARG SEQRES 4 A 231 ILE SER ASN CYS VAL ALA ASP TYR SER VAL LEU TYR ASN SEQRES 5 A 231 SER ALA SER PHE SER THR PHE LYS CYS TYR GLY VAL SER SEQRES 6 A 231 PRO THR LYS LEU ASN ASP LEU CYS PHE THR ASN VAL TYR SEQRES 7 A 231 ALA ASP SER PHE VAL ILE ARG GLY ASP GLU VAL ARG GLN SEQRES 8 A 231 ILE ALA PRO GLY GLN THR GLY ASN ILE ALA ASP TYR ASN SEQRES 9 A 231 TYR LYS LEU PRO ASP ASP PHE THR GLY CYS VAL ILE ALA SEQRES 10 A 231 TRP ASN SER ASN ASN LEU ASP SER LYS VAL GLY GLY ASN SEQRES 11 A 231 TYR ASN TYR LEU TYR ARG LEU PHE ARG LYS SER ASN LEU SEQRES 12 A 231 LYS PRO PHE GLU ARG ASP ILE SER THR GLU ILE TYR GLN SEQRES 13 A 231 ALA GLY SER THR PRO CYS ASN GLY VAL LYS GLY PHE ASN SEQRES 14 A 231 CYS TYR PHE PRO LEU GLN SER TYR GLY PHE GLN PRO THR SEQRES 15 A 231 TYR GLY VAL GLY TYR GLN PRO TYR ARG VAL VAL VAL LEU SEQRES 16 A 231 SER PHE GLU LEU LEU HIS ALA PRO ALA THR VAL CYS GLY SEQRES 17 A 231 PRO LYS LYS SER THR ASN LEU VAL LYS ASN LYS CYS VAL SEQRES 18 A 231 ASN PHE SER GLY HIS HIS HIS HIS HIS HIS SEQRES 1 H 221 GLU VAL GLN LEU VAL GLU SER GLY GLY GLY LEU VAL GLN SEQRES 2 H 221 PRO GLY GLY SER LEU ARG LEU SER CYS ALA ALA SER GLY SEQRES 3 H 221 PHE THR VAL SER SER ASN TYR MET ASN TRP VAL ARG GLN SEQRES 4 H 221 ALA PRO GLY LYS GLY LEU GLU TRP VAL SER VAL ILE TYR SEQRES 5 H 221 SER GLY GLY SER THR TYR TYR ALA ASP SER VAL LYS GLY SEQRES 6 H 221 ARG PHE THR ILE SER ARG HIS ASN SER LYS ASN THR LEU SEQRES 7 H 221 TYR LEU GLN MET ASN SER LEU ARG ALA GLU ASP THR ALA SEQRES 8 H 221 VAL TYR TYR CYS ALA ARG GLY THR ALA MET ALA TYR GLY SEQRES 9 H 221 MET ASP VAL TRP GLY GLN GLY THR THR VAL THR VAL SER SEQRES 10 H 221 SER ALA SER THR LYS GLY PRO SER VAL PHE PRO LEU ALA SEQRES 11 H 221 PRO SER SER LYS SER THR SER GLY GLY THR ALA ALA LEU SEQRES 12 H 221 GLY CYS LEU VAL LYS ASP TYR PHE PRO GLU PRO VAL THR SEQRES 13 H 221 VAL SER TRP ASN SER GLY ALA LEU THR SER GLY VAL HIS SEQRES 14 H 221 THR PHE PRO ALA VAL LEU GLN SER SER GLY LEU TYR SER SEQRES 15 H 221 LEU SER SER VAL VAL THR VAL PRO SER SER SER LEU GLY SEQRES 16 H 221 THR GLN THR TYR ILE CYS ASN VAL ASN HIS LYS PRO SER SEQRES 17 H 221 ASN THR LYS VAL ASP LYS LYS VAL GLU PRO LYS SER CYS SEQRES 1 L 213 TYR GLU LEU THR GLN PRO PRO SER VAL SER VAL ALA PRO SEQRES 2 L 213 GLY GLN THR ALA ARG ILE THR CYS GLY GLY ASN ASN ILE SEQRES 3 L 213 GLY GLY GLN SER VAL HIS TRP TYR GLN GLN LYS PRO GLY SEQRES 4 L 213 GLN ALA PRO VAL LEU VAL VAL TYR ASP ASP SER ASP ARG SEQRES 5 L 213 PRO SER GLY ILE PRO GLU ARG PHE SER GLY SER ASN SER SEQRES 6 L 213 GLY ASN THR ALA THR LEU THR ILE SER ARG VAL GLU ALA SEQRES 7 L 213 GLY ASP GLU ALA ASP TYR TYR CYS GLN VAL TRP ASP SER SEQRES 8 L 213 SER SER ASP HIS VAL VAL PHE GLY GLY GLY THR LYS LEU SEQRES 9 L 213 THR VAL LEU GLY GLN PRO LYS ALA ALA PRO SER VAL THR SEQRES 10 L 213 LEU PHE PRO PRO SER SER GLU GLU LEU GLN ALA ASN LYS SEQRES 11 L 213 ALA THR LEU VAL CYS LEU ILE SER ASP PHE TYR PRO GLY SEQRES 12 L 213 ALA VAL THR VAL ALA TRP LYS ALA ASP SER SER PRO VAL SEQRES 13 L 213 LYS ALA GLY VAL GLU THR THR THR PRO SER LYS GLN SER SEQRES 14 L 213 ASN ASN LYS TYR ALA ALA SER SER TYR LEU SER LEU THR SEQRES 15 L 213 PRO GLU GLN TRP LYS SER HIS ARG SER TYR SER CYS GLN SEQRES 16 L 213 VAL THR HIS GLU GLY SER THR VAL GLU LYS THR VAL ALA SEQRES 17 L 213 PRO THR GLU CYS SER HET NAG A 601 14 HET SO4 A 602 5 HET SO4 A 603 5 HET SO4 A 604 5 HET SO4 A 605 5 HET SO4 H 301 5 HET SO4 H 302 5 HET SO4 H 303 5 HET EDO H 304 4 HET SO4 L 301 5 HET SO4 L 302 5 HET SO4 L 303 5 HET SO4 L 304 5 HET SO4 L 305 5 HET SO4 L 306 5 HET EDO L 307 4 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM SO4 SULFATE ION HETNAM EDO 1,2-ETHANEDIOL HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN EDO ETHYLENE GLYCOL FORMUL 4 NAG C8 H15 N O6 FORMUL 5 SO4 13(O4 S 2-) FORMUL 12 EDO 2(C2 H6 O2) FORMUL 20 HOH *29(H2 O) HELIX 1 AA1 PHE A 338 ASN A 343 1 6 HELIX 2 AA2 SER A 349 TRP A 353 5 5 HELIX 3 AA3 ASP A 364 ASN A 370 1 7 HELIX 4 AA4 SER A 383 ASN A 388 1 6 HELIX 5 AA5 ASP A 405 ILE A 410 5 6 HELIX 6 AA6 GLY A 416 ASN A 422 1 7 HELIX 7 AA7 SER A 438 SER A 443 1 6 HELIX 8 AA8 GLY A 502 TYR A 505 5 4 HELIX 9 AA9 THR H 28 ASN H 32 5 5 HELIX 10 AB1 ASP H 61 LYS H 64 5 4 HELIX 11 AB2 ARG H 83 THR H 87 5 5 HELIX 12 AB3 PRO H 185 LEU H 189 5 5 HELIX 13 AB4 ASN L 27 GLN L 31 5 5 HELIX 14 AB5 GLU L 79 GLU L 83 5 5 HELIX 15 AB6 SER L 121 ALA L 127 1 7 HELIX 16 AB7 THR L 181 SER L 187 1 7 SHEET 1 AA1 5 ASN A 354 ILE A 358 0 SHEET 2 AA1 5 ASN A 394 ARG A 403 -1 O SER A 399 N ASN A 354 SHEET 3 AA1 5 PRO A 507 GLU A 516 -1 O TYR A 508 N ILE A 402 SHEET 4 AA1 5 GLY A 431 ASN A 437 -1 N ILE A 434 O VAL A 511 SHEET 5 AA1 5 THR A 376 TYR A 380 -1 N TYR A 380 O GLY A 431 SHEET 1 AA2 2 CYS A 391 PHE A 392 0 SHEET 2 AA2 2 VAL A 524 CYS A 525 -1 O VAL A 524 N PHE A 392 SHEET 1 AA3 2 LEU A 452 ARG A 454 0 SHEET 2 AA3 2 LEU A 492 SER A 494 -1 O GLN A 493 N TYR A 453 SHEET 1 AA4 2 TYR A 473 GLN A 474 0 SHEET 2 AA4 2 CYS A 488 TYR A 489 -1 O TYR A 489 N TYR A 473 SHEET 1 AA5 4 GLN H 3 SER H 7 0 SHEET 2 AA5 4 LEU H 18 SER H 25 -1 O SER H 21 N SER H 7 SHEET 3 AA5 4 THR H 77 MET H 82 -1 O LEU H 78 N CYS H 22 SHEET 4 AA5 4 PHE H 67 HIS H 72 -1 N SER H 70 O TYR H 79 SHEET 1 AA6 6 GLY H 10 VAL H 12 0 SHEET 2 AA6 6 THR H 107 VAL H 111 1 O THR H 110 N GLY H 10 SHEET 3 AA6 6 ALA H 88 THR H 96 -1 N TYR H 90 O THR H 107 SHEET 4 AA6 6 MET H 34 GLN H 39 -1 N VAL H 37 O TYR H 91 SHEET 5 AA6 6 LEU H 45 ILE H 51 -1 O GLU H 46 N ARG H 38 SHEET 6 AA6 6 THR H 57 TYR H 59 -1 O TYR H 58 N VAL H 50 SHEET 1 AA7 4 GLY H 10 VAL H 12 0 SHEET 2 AA7 4 THR H 107 VAL H 111 1 O THR H 110 N GLY H 10 SHEET 3 AA7 4 ALA H 88 THR H 96 -1 N TYR H 90 O THR H 107 SHEET 4 AA7 4 GLY H 100A TRP H 103 -1 O VAL H 102 N ARG H 94 SHEET 1 AA8 4 SER H 120 LEU H 124 0 SHEET 2 AA8 4 ALA H 136 TYR H 145 -1 O LEU H 141 N PHE H 122 SHEET 3 AA8 4 TYR H 176 VAL H 184 -1 O VAL H 182 N LEU H 138 SHEET 4 AA8 4 VAL H 163 THR H 165 -1 N HIS H 164 O VAL H 181 SHEET 1 AA9 4 SER H 120 LEU H 124 0 SHEET 2 AA9 4 ALA H 136 TYR H 145 -1 O LEU H 141 N PHE H 122 SHEET 3 AA9 4 TYR H 176 VAL H 184 -1 O VAL H 182 N LEU H 138 SHEET 4 AA9 4 VAL H 169 LEU H 170 -1 N VAL H 169 O SER H 177 SHEET 1 AB1 3 THR H 151 TRP H 154 0 SHEET 2 AB1 3 TYR H 194 HIS H 200 -1 O ASN H 199 N THR H 151 SHEET 3 AB1 3 THR H 205 VAL H 211 -1 O LYS H 209 N CYS H 196 SHEET 1 AB2 5 SER L 9 VAL L 13 0 SHEET 2 AB2 5 THR L 102 VAL L 106 1 O THR L 105 N VAL L 11 SHEET 3 AB2 5 ALA L 84 ASP L 92 -1 N ALA L 84 O LEU L 104 SHEET 4 AB2 5 HIS L 34 GLN L 38 -1 N GLN L 38 O ASP L 85 SHEET 5 AB2 5 VAL L 45 VAL L 48 -1 O VAL L 45 N GLN L 37 SHEET 1 AB3 4 SER L 9 VAL L 13 0 SHEET 2 AB3 4 THR L 102 VAL L 106 1 O THR L 105 N VAL L 11 SHEET 3 AB3 4 ALA L 84 ASP L 92 -1 N ALA L 84 O LEU L 104 SHEET 4 AB3 4 HIS L 95B PHE L 98 -1 O HIS L 95B N ASP L 92 SHEET 1 AB4 3 ALA L 19 GLY L 24 0 SHEET 2 AB4 3 THR L 70 ILE L 75 -1 O ILE L 75 N ALA L 19 SHEET 3 AB4 3 PHE L 62 SER L 67 -1 N SER L 63 O THR L 74 SHEET 1 AB5 4 SER L 114 PHE L 118 0 SHEET 2 AB5 4 THR L 131 PHE L 139 -1 O SER L 137 N SER L 114 SHEET 3 AB5 4 TYR L 172 SER L 179 -1 O SER L 176 N CYS L 134 SHEET 4 AB5 4 VAL L 159 THR L 161 -1 N GLU L 160 O TYR L 177 SHEET 1 AB6 4 SER L 114 PHE L 118 0 SHEET 2 AB6 4 THR L 131 PHE L 139 -1 O SER L 137 N SER L 114 SHEET 3 AB6 4 TYR L 172 SER L 179 -1 O SER L 176 N CYS L 134 SHEET 4 AB6 4 SER L 165 LYS L 166 -1 N SER L 165 O ALA L 173 SHEET 1 AB7 4 SER L 153 VAL L 155 0 SHEET 2 AB7 4 THR L 145 ALA L 150 -1 N ALA L 150 O SER L 153 SHEET 3 AB7 4 TYR L 191 HIS L 197 -1 O GLN L 194 N ALA L 147 SHEET 4 AB7 4 SER L 200 VAL L 206 -1 O LYS L 204 N CYS L 193 SSBOND 1 CYS A 336 CYS A 361 1555 1555 2.04 SSBOND 2 CYS A 379 CYS A 432 1555 1555 2.04 SSBOND 3 CYS A 391 CYS A 525 1555 1555 2.04 SSBOND 4 CYS A 480 CYS A 488 1555 1555 2.04 SSBOND 5 CYS H 22 CYS H 92 1555 1555 2.03 SSBOND 6 CYS H 140 CYS H 196 1555 1555 2.03 SSBOND 7 CYS L 23 CYS L 88 1555 1555 2.04 SSBOND 8 CYS L 134 CYS L 193 1555 1555 2.03 LINK ND2 ASN A 343 C1 NAG A 601 1555 1555 1.44 CISPEP 1 PHE H 146 PRO H 147 0 -4.63 CISPEP 2 GLU H 148 PRO H 149 0 -2.45 CISPEP 3 TYR L 140 PRO L 141 0 1.97 CRYST1 145.898 145.898 111.994 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006854 0.000000 0.000000 0.00000 SCALE2 0.000000 0.006854 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008929 0.00000